Countries
- Argentina

- Armenia

- Australia

- Austria

- Belarus

- Belgium

- Brazil

- Bulgaria

- Canada

- Chile

- China

- Colombia

- Croatia

- Cyprus

- Czech Republic

- Denmark

- Ecuador

- Egypt

- England

- Estonia

- Finland

- France

- Georgia

- Germany

Featured Companies
CATO Research
Cato Research is a contract research organization (CRO) that provides integrated services to pharmaceutical, biotechnology, and medical device companies.…
Northern California Research
Our practice philosophy is an extension of the philosophy of life that we share. We love our roles in research and development, as well as, the advancement…
Squarepoint-Pointcarre
We are a dynamic and innovative team of scientists, specialized in biology, pharmacy, pharmacology, data management, biostatistics, medical writing and…
IQVIA BIOTECH
Having a team with expertise in your therapeutic area is crucial to the success of your clinical development program. You want a team that’s done it before – a team that understands the nuances of your therapeutic area and indication. We know the approach to finding patients in oncology is different than in dermatology. Understanding regulatory and approval pathways is an entirely different journey in pediatrics than it is for Alzheimer’s treatments. That’s why we ensure your study will be managed by a hand-selected team with experience specific to your phase and your indication
ResearchPoint Global
ResearchPoint Global is a full-service CRO with 15 global offices and clinical coverage in over 60 countries. Founded in 1999, ResearchPoint Global (RPG)…
Medicines Evaluation Unit (MEU)
The Medicines Evaluation Unit (MEU) Ltd is one of the UK’s leading contract research organisations, and a facility where commitment to excellence…
Strategic Regulatory Consulting
Why Choose SRC? Whether you are a startup or a large multinational company, you can benefit from the experience and expertise of SRC to meet your objectives…
Concentrics Research
For nearly 30 years, Concentrics Research has been a leader in the conduct of Rx-to-OTC Switch and late-stage (Phase II-IV) research for the pharmaceutical,…















































